8th Plenary Meeting EHDN 2014 Barcelona: 19-21 settembre 2014 – Report

Annarita Bentivoglio* - Marina Frontali** Si è appena concluso l’ottavo meeting plenario del Network Europeo per la Malattia di Huntington. Oltre 900 partecipanti: l’incontro più numeroso...

Fatal cellular malfunction identified in Huntington’s disease

Researchers believe they have learned how mutations in the gene that causes Huntington’s disease kill brain cells, a finding that could open new opportunities...

New molecule can reverse the Huntington’s disease mutation in lab models

A collaborative team of scientists from Canada and Japan have identified a small molecule which can change the CAG-repeat length in different lab models...

Huntington’s disease therapeutics conference 2020 – Day 3

HDBuzz reports from the annual Huntington’s disease therapeutics conference in Palm Springs Rachel and Sarah report from the Huntington’s Disease Therapeutics Conference - the biggest annual...

CHDI head scientist Pacifici: ‘hang on in the learning roller coaster...

With historic clinical trials now aiming for the first effective treatments for Huntington’s disease, affected individuals and their families need to clearly understand the...

Huntington’s disease therapeutics conference 2020 – Day 2

HDBuzz reports from the annual Huntington’s disease therapeutics conference in Palm Springs Rachel and Sarah report from the Huntington’s Disease Therapeutics Conference - the biggest annual...

At Therapeutics Conference, landmark study of young gene carriers highlights how...

Armed with ever more impressive data and a deeper understanding of Huntington’s disease, scientists and drug hunters convened at the 15th Annual HD Therapeutics...

Huntington’s disease therapeutics conference 2020 – Day 1

HDBuzz reports from the annual Huntington’s disease therapeutics conference in Palm Springs Our new writers Rachel Harding and Sarah Hernandez report from the Huntington’s Disease Therapeutics Conference...

uniQure Presents Multiple New Preclinical Data on AMT-130 at the CHDI’s...

~ Up to Two Years of Follow-up in Large Transgenic Huntington’s Disease Model Demonstrates Stable mHTT Protein Lowering ~  ~ Novel Preclinical Data Demonstrates Successful...

Huntington’s disease-causing DNA repeat mutations reversed in the lab

Neurodegenerative diseases, like Huntington’s disease and myotonic dystrophy, are often referred to as DNA repeat diseases, named because of long repeated sequences in the...

Screening the entire genome for new drug targets for HD Scientists...

This ambitious study provides a wealth of data for HD researchers Arecently published study in the journal ‘Neuron’ has identified new potential therapeutic targets for...
Language disorders as indicators of the diagnosis and progression of Huntington’s disease

Language disorders as indicators of the diagnosis and progression of Huntington’s...

A study led by Wolfram Hinzen, ICREA research professor with the Department of Translation and Language Sciences, published in Journal of Communication Disorders, shows that the...

Wave Life Sciences to Present Preclinical In Vivo and In Vitro...

Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage genetic medicines company committed to delivering life-changing treatments for people battling devastating diseases, today announced that it...

A new cohort of iPSC lines available from EBiSC will accelerate...

The European Bank for induced Pluripotent Stem Cells (EBiSC) and CHDI Foundation have collaborated with Censo Biotechnologies to generate a cohort of 45 iPSC...

I’m a Huntington’s disease gene carrier at age 60, so why...

Huntington’s disease struck my mother in her late 40s, turned her into a debilitated, mere shadow of herself by her late 50s, and took...

Genetic screen offers new drug targets for Huntington’s disease

Using a type of genetic screen that had previously been impossible in the mammalian brain, MIT neuroscientists have identified hundreds of genes that are...

Helping Advance Huntington’s Disease Research by Using AI to Map the...

Neurodegenerative diseases are disorders that progressively affect neurons in the brain, altering their function and causing their death. They include many different disorders, such...

uniQure Announces Publication of Preclinical Data for AMT-130 in Huntington’s Disease...

LEXINGTON, Mass. and AMSTERDAM, the Netherlands, Dec. 19, 2019 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients...

NEUROSCIENTISTS FIND NEW ROLES FOR HUNTINGTON’S PROTEIN

Crucial role in synapse formation could be new avenue toward treatment A Duke University research team has identified a new function of a gene called...

Planning a ‘Dancing at the Vatican’ screening to celebrate the global...

On February 19, the University of San Diego (USD) will host the world’s third screening of Dancing at the Vatican, the short documentary featuring South American Huntington’s disease-afflicted...

Unpacking Wave’s PRECISION-HD2 huntingtin-lowering trial announcement

Wave Life Sciences announces that its antisense drug WVE-120102 has lowered mutant huntingtin protein in cerebrospinal fluid, but investors seem disappointed. Rather confusing –...

New way to identify and track progression of Huntington’s disease

Researchers at the universities of Southampton and Cambridge have developed a new technique to analyse biochemical changes unique to Huntington’s disease. The breakthrough has...